1. Home
  2. ONC vs TPR Comparison

ONC vs TPR Comparison

Compare ONC & TPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$276.64

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Logo Tapestry Inc.

TPR

Tapestry Inc.

HOLD

Current Price

$138.65

Market Cap

31.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONC
TPR
Founded
2010
1941
Country
Switzerland
United States
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
33.5B
31.8B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ONC
TPR
Price
$276.64
$138.65
Analyst Decision
Strong Buy
Buy
Analyst Count
11
16
Target Price
$377.91
$142.20
AVG Volume (30 Days)
242.5K
1.7M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
1.12%
EPS Growth
N/A
N/A
EPS
N/A
3.93
Revenue
N/A
$5,880,000,000.00
Revenue This Year
$759.19
$12.39
Revenue Next Year
$14.51
$5.36
P/E Ratio
$614.06
$36.30
Revenue Growth
N/A
31.01
52 Week Low
$196.53
$60.13
52 Week High
$385.22
$161.97

Technical Indicators

Market Signals
Indicator
ONC
TPR
Relative Strength Index (RSI) 28.89 42.06
Support Level $239.25 $138.09
Resistance Level $284.51 $160.13
Average True Range (ATR) 7.11 4.91
MACD -2.02 -1.66
Stochastic Oscillator 1.35 13.44

Price Performance

Historical Comparison
ONC
TPR

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

About TPR Tapestry Inc.

Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.

Share on Social Networks: